ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $181,000 | -34.7% | 161,479 | -8.8% | 0.00% | – |
| Q2 2021 | $277,000 | -32.1% | 177,147 | -18.4% | 0.00% | – |
| Q1 2021 | $408,000 | -2.9% | 217,068 | -18.8% | 0.00% | – |
| Q4 2020 | $420,000 | +50.5% | 267,414 | -1.9% | 0.00% | – |
| Q3 2020 | $279,000 | -58.4% | 272,616 | +18.6% | 0.00% | – |
| Q2 2020 | $670,000 | +96.5% | 229,955 | +41.5% | 0.00% | – |
| Q1 2020 | $341,000 | -37.3% | 162,480 | -2.3% | 0.00% | – |
| Q4 2019 | $544,000 | +70.5% | 166,308 | +17.9% | 0.00% | – |
| Q3 2019 | $319,000 | -24.8% | 141,087 | +59.0% | 0.00% | – |
| Q2 2019 | $424,000 | -21.0% | 88,714 | +21.7% | 0.00% | – |
| Q1 2019 | $537,000 | +3.1% | 72,913 | 0.0% | 0.00% | – |
| Q4 2018 | $521,000 | -44.2% | 72,913 | 0.0% | 0.00% | – |
| Q3 2018 | $933,000 | +240.5% | 72,913 | +322.0% | 0.00% | – |
| Q4 2017 | $274,000 | -21.9% | 17,279 | -16.1% | 0.00% | – |
| Q3 2017 | $351,000 | +165.9% | 20,584 | 0.0% | 0.00% | – |
| Q2 2017 | $132,000 | +28.2% | 20,584 | 0.0% | 0.00% | – |
| Q1 2017 | $103,000 | -7.2% | 20,584 | -10.4% | 0.00% | – |
| Q4 2016 | $111,000 | -19.6% | 22,977 | 0.0% | 0.00% | – |
| Q3 2016 | $138,000 | – | 22,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,359,767 | $3,481,000 | 1.41% |
| DAFNA Capital Management LLC | 181,818 | $465,000 | 0.40% |
| Perceptive Advisors | 1,762,881 | $4,512,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 468,050 | $1,198,000 | 0.26% |
| Soros Fund Management | 1,462,122 | $3,743,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 334,108 | $855,000 | 0.04% |
| KLCM Advisors, Inc. | 28,612 | $73,000 | 0.02% |
| CAMBRIDGE TRUST CO | 65,414 | $167,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 35,400 | $91,000 | 0.01% |
| IFP Advisors, Inc | 10,000 | $74,000 | 0.01% |